Skip to main content

Table 1 Patient characteristics and tumor identification and staging

From: Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?

 

Control

PDAC

NRPT

BDAC

AC

EC

CP

N Patients Pre surg.

20

25

6

4

6

5

7

N Patients Post surg.

N/A

16

  

6

4

6

Males

12

15

5

3

6

2

3

Females

8

10

1

1

0

3

4

Median age (range)

66 (49-86)

68 (47-78)

66 (51-74)

75 (65-78)

67 (53-75)

58 (46-67)

67 (59-72)

TNM

       

1A

    

1

3

 

1B

 

4

 

1

3

1

 

2A

 

1

   

1

 

2B

 

19

 

3

1

  

3

    

1

  

4

 

1

     

Differentiation

       

G1

 

5

  

2

2

 

G2

 

13

 

1

3

  

G3

 

7

 

3

   

Not evaluated

    

1

3

 
  1. Pancreatic ductal adenocarcinoma (PDAC), None resectable pancreatic tumor (NRPT), billary duct adenocarcinoma (BDCA), ampullary carcinoma (AC), endocrine carcinoma (EC), chronic pancreatitis (CP), not applicable (N/A), Tumour, Node, Metastasis (TNM), number (N)